The data forecasts a consistent mortality rate for bladder malignant neoplasms in Japan from 2024 to 2028, maintaining a level of 3.8 deaths per hundred thousand persons, standardized rates. This stability follows actual data from 2023, suggesting no significant change year-on-year. With no variation over the last two years and a steady rate over the next five, the compound annual growth rate (CAGR) remains neutral, reflecting stable trends in the disease's mortality rate.

Future trends to watch for:

Improved healthcare interventions and early detection methods that could impact mortality rates.
Potential demographic changes affecting bladder cancer incidence and mortality.
Advancements in treatment options that may alter survival outcomes and influence mortality rates.